Skip to content

DR. WAELBERS

Active
Private limited companyfounded 20197 yrs activeHeirstraat(HEF) 20, 2801 Mechelen, BelgiumKBO/BCE: BE 0732.933.681

DR. WAELBERS has been active since 2019 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €1k and a net result of €247k. Equity is growing by ~25.5% per year across the filed fiscal years. Its solvency ranks better than 5% of 16491 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).

Checked score

Score 2025
71 / 100
Healthy
The score weighs solvency, liquidity and profitability. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability100=
Solvency25=
Growth78=
Track record100
Bankruptcy probability, 12 months
0.1% Very low
0%0.5%1.5%4%10%≥ 25%
Credit advice for your own amount and term

Signals

Seven signals. The signal on the left, the evidence on the right.
lowers risk+raises riskneutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Sector 86
lower
← fewer bankruptcies more bankruptcies →
raises risk · Limited track record
This company has not been active as long as an established one and statistically fails somewhat more often.
KBO · incorporation date
Age against the risk zone
elevated failure risk from 2 to 8 years 7 years 0 10 y
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025
Solvency, return and age of the figures
Solvency
0.4%
Return on assets
94.6%
Age of the figures
9 mo
raises risk · Weak solvency vs sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 5% of 16491 sector peers (2025).
NBB · sector comparison
Position among 16491 sector peers
Solvency
better than 5%
← weakest strongest →
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 28-05-2026, 64 days ahead of the deadline.
NBB · 7 filings
Deviation from the deadline
2025
64 d early
2024
7 d late
2023
29 d late
2022
28 d late
2021
19 d late
2020
25 d late
2019
24 d late
← before the deadline after the deadline →
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven months
Position in the running window
19-09-2026 today31-12-2026 close31-07-2027 deadline
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage

Financials · fiscal year 2025, micro schema

Equity
€1k=
2024 · €1k
2019: €-2k 2020: €-9k 2021: €34k 2022: €99k 2023: €1k 2024: €1k
2019 → 2025
Total assets
€261k▲ 13.7%
2024 · €229k
2019: €15k 2020: €10k 2021: €132k 2022: €188k 2023: €176k 2024: €229k
2019 → 2025
Net result
€247k▲ 22.5%
2024 · €201k
2019: €-3k 2020: €-7k 2021: €44k 2022: €65k 2023: €81k 2024: €201k
2019 → 2025
Working capital
€-33k▼ 5.6%
2024 · €-31k
2019: €-2k 2020: €-9k 2021: €24k 2022: €90k 2023: €-10k 2024: €-31k
2019 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise ▼ fall
Line20212022202320242025Trend
Equity€34k-€99k▲ 188%€1k▼ 99.0%€1k=€1k=
Operating result€53k-€83k▲ 56.2%€104k▲ 25.4%€263k▲ 152%€322k▲ 22.6%
Net result€44k-€65k▲ 47.9%€81k▲ 25.2%€201k▲ 149%€247k▲ 22.5%
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
€0€100k€200k€300kOperating result 2021: €53k€53kNet result 2021: €44k€44kOperating result 2022: €83k€83kNet result 2022: €65k€65kOperating result 2023: €104k€104kNet result 2023: €81k€81kOperating result 2024: €263k€263kNet result 2024: €201k€201kOperating result 2025: €322k€322kNet result 2025: €247k€247k20212022202320242025
The operating result has risen four years in a row; 2025 is 23% above 2024 and is the highest result in the available series.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €261k
Fixed assets €34k▼ 17.4%
Current assets €227k▲ 20.6%
Equity and liabilities €261k
Equity €1k=
Debt €260k▲ 13.8%
The debt ratio rises from 99.6% to 99.6%. Debt is higher.
Key figures and ratios
2025 value · change against 2024
EBITDA
€338k
2024 · €278k
Cash flow
€262k
2024 · €216k
Solvency
0.4%
2024 · 0.4%
Current ratio
0.87
2024 · 0.86
Quick ratio
0.87
2024 · 0.86
ROA
94.6%
2024 · 87.8%
Interest coverage
929.89
2024 · 693.29
Debt
€260k
2024 · €228k
Debt ≤ 1 year
€260k
2024 · €219k
Debt > 1 year
€0
2024 · €9k
Income taxes
€75k
2024 · €61k
A ratio outside any meaningful range has been withheld (balance sheet total €261k, equity €1k).
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2025 against 2024
Balance sheet Code20242025
Assets
Total assets20/58€229k€261k
Fixed assets21/28€42k€34k
Tangible fixed assets22/27€42k€34k
Plant, machinery and equipment23€22k€19k
Furniture and vehicles24€20k€15k
Current assets29/58€188k€227k
Amounts receivable within one year40/41€4k€37k
Other amounts receivable41€4k€37k
Cash at bank and in hand54/58€160k€166k
Deferred charges and accrued income490/1€24k€24k
Equity and liabilities
Total equity and liabilities10/49€229k€261k
Equity10/15€1k€1k=
Contributions10/11€1k€1k=
Profit (loss) carried forward14€0€0=
Amounts payable17/49€228k€260k
Amounts payable after more than one year17€9k€0
Financial debts170/4€9k€0
Amounts payable within one year42/48€219k€260k
Current portion of amounts payable after more than one year42€12k€9k
Trade debts44€3k€51
Suppliers440/4€3k€51
Taxes, remuneration and social security45€0€23k
Taxes450/3€0€23k
Remuneration and social security454/9€0-
Other amounts payable47/48€204k€228k
Accrued charges and deferred income492/3€188€193
Income statement Code20242025
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€15k€15k
Other operating charges640/8€528€603
Non-recurring operating charges66A-€1k
Gross operating margin9900€278k€339k
Operating profit (loss)9901€263k€322k
Financial charges65/66B€401€363
Recurring financial charges65€401€363
Profit (loss) for the period before taxes9903€263k€322k
Income taxes67/77€61k€75k
Profit (loss) for the period9904€201k€247k
Profit (loss) for the period to be appropriated9905€201k€247k
Appropriation of the result
Profit (loss) to be appropriated9906€201k€247k
Transfer from equity791/2€0-
Profit to be distributed694/7€201k€247k
Return on contributions (dividend)694€201k€241k
Directors or managers695-€6k

The notes to these accounts (9 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Download as CSV

Timeline · acts, filings and financial milestones

Next filing, fiscal year 2026, expected by 31-07-2027
2026
28-05
NBB filing Annual accounts filed
fiscal year 2025 · micro schema
2025
31-12
Financial Highest result since 2019net €247k ▲22.5%
Operating result €322k, net result €247k, both a record.
07-08
NBB filing Annual accounts filed
fiscal year 2024 · micro schema · 7 days late
2024
29-08
NBB filing Annual accounts filed
fiscal year 2023 · micro schema · 29 days late
2023
28-08
NBB filing Annual accounts filed
fiscal year 2022 · micro schema · 28 days late
2022
19-08
NBB filing Annual accounts filed
fiscal year 2021 · micro schema · 19 days late
2021
31-12
Financial Back to profitnet €44k
Net result €44k after 2 loss-making years.
31-12
Financial Liquidity triplescurrent ratio 1.46
Current ratio from 0.52 to 1.46.
25-08
NBB filing Annual accounts filed
fiscal year 2020 · micro schema · 25 days late
2020
31-12
Financial Weakest financial yearnet €-7k
Net result drops to €-7k, the lowest in the series; recovery starts the following year.
24-08
NBB filing Annual accounts filed
fiscal year 2019 · micro schema · 24 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.

Directors · office · real estate

Directors
1 act for this company is in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Mechelen · 1 establishment unit since 2019
establishment The establishment unit on the map
Cannot be placed on the map

This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.

Heirstraat(HEF) 202801 Mechelen
Ground area
2,514 m²
Building footprint
187 m²
Volume, LiDAR
1,077 m³
Parcel 12012C0396/00B000, Flanders · tallest building 9.1 m, ±2 floors. Linked by address, not a title deed.
1 establishment unit
DR. WAELBERS
Heirstraat(HEF) 20, 2801 MechelenSpecialist medical practice
since 20192.294.826.790
1 parcel
Flanders 1 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
12012C0396/00B000 Flanders 2,513 m² 1 · 187 m² 9.1 m · 2 fl.
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Similar companies · same sector, comparable size

Of 16,627 companies in sector 86220 we hold annual accounts for 7,973. 553 are within a factor 10 of this equity.See the whole sector

Company data · Crossroads Bank

Identification
Legal formPrivate limited company
Founded27-08-2019
Fiscal year end31-12
Activities, NACEBEL
86220Specialist medical practice
82100Office administrative and support services
82110Office administrative, office support and other business support activities
82990Other business support services
Sources
Crossroads Bank for EnterprisesNational Bank · 7 filingsAddress and cadastre registers

Data from official sources, last processed on 19-09-2026. Scores and ratios are computed by Checked and are not a credit decision.